Article Information
History
- March 26, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Dominic Wooding1,#,
- Kate Buist1,#,
- Alessandra Romero-Ramirez1,#,
- Helen Savage2,
- Rachel Watkins1,
- Daisy Bengey1,
- Caitlin Greenland-Bews1,
- Caitlin R Thompson1,
- Nadia Kontogianni1,
- Richard Body3,
- Gail Hayward4,
- Rachel L Byrne2,
- Susan Gould1,
- CONDOR Steering Group3,
- Christopher Myerscough1,
- Barry Atkinson6,
- Victoria Shaw5,
- Bill Greenhalf5,
- Emily Adams1,
- Ana Cubas-Atienzar1,
- Saye Khoo5,7,
- Tom Fletcher2,7 and
- Thomas Edwards1,*
- 1Centre for Drugs and Diagnostics, Liverpool School of Tropical Medicine and Hygiene, Liverpool, United Kingdom
- 2Department of Clinical Sciences, Liverpool School of Tropical Medicine and Hygiene, Liverpool, UK
- 3Manchester University NHS Foundation Trust, Research and Innovation, Manchester, UK
- 4Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
- 5University of Liverpool, Liverpool, UK
- 6Research and Evaluation, UK Health Security Agency, Porton Down, Salisbury SP4 0JG, UK
- 7NIHR Royal Liverpool and Broadgreen CRF, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK
- ↵*Corresponding Author Correspondence Dr Thomas Edwards, email:
thomas.edwards{at}lstmed.ac.uk
↵# Joint first author, contributed equally
Posted March 26, 2024.
Optimisation of SARS-CoV-2 culture from clinical samples for clinical trial applications
